KIDSWELL BIO CORPORATION revenue breakdown overview

KIDSWELL BIO CORPORATION revenue for the last year amounted to 5.08 B JPY, the most of which — 4.72 B JPY — came from its highest performing source at the moment, Biosimilars - Pharmaceutical Ingredients. The greatest contribution to the revenue figure was made by Japan — last year it brought KIDSWELL BIO CORPORATION 5.08 B JPY, and the year before that — 2.43 B JPY.